Tonix Pharmaceuticals Holding Corp. (TPM.F)
| Previous close | 0.5320 |
| Open | 0.5360 |
| Bid | 0.5560 x N/A |
| Ask | 0.5780 x N/A |
| Day's range | 0.5360 - 0.5360 |
| 52-week range | 0.5180 - 16.7168 |
| Volume | |
| Avg. volume | 2,073 |
| Market cap | 24.53M |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -7.1320 |
| Earnings date | 07 Nov 2022 - 11 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Tonix Pharmaceuticals Announces IND Clearance for TNX-601 ER as a Potential Treatment for Major Depressive Disorder
TNX-601 ER, Tianeptine Hemioxalate, is an Extended-Release Tablet for Once-a-Day Dosing Phase 2 Clinical Trial of TNX-601 ER Expected to Start First Quarter 2023 CHATHAM, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to support a Phase 2 clinical trial with TNX-601 ER
- GlobeNewswire
New to The Street TV / Newsmax TV Announces Its Corporate Interviews on Episode #389, Airing Sunday, September 25, 2022, 10-11 AM ET
New to The Street TV / Newsmax TV Announces Its Corporate Interviews on Episode #389 1). PetVivo Holdings, Inc. (NASDAQ: PETV) (NASDAQ: PETVW) ($PETV) 2). Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP) ($TNXP) 3). Coastal Kapital, LLC 4). Blue Castle Ventures LTD’s (CRYPTO: BCVD) ($BCVD) 5). Sekur Private Data, Ltd.’s (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) 6). Phixey, Inc. 7). “Sekur Privacy & Sekur Security Segment” - Sekur Private Data Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) (Sekur®). NEW YORK
- GlobeNewswire
Tonix Pharmaceuticals Presents Data from Retrospective Observational Database Study on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients at IASP 2022 World Congress on Pain
Approximately 40% of Long COVID Patients Experience Multi-Site Pain Similar to Overlapping Chronic Pain Syndromes Fibromyalgia and ME/CFS Approximately 50% of Long COVID Patients with Multi-Site Pain and Sleep Disturbance Use Opiates CHATHAM, N.J., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced data from a retrospective observational database study in patients diagnosed with
